文献
J-GLOBAL ID:201202205430418155
整理番号:12A1349372
日本人転移性結腸直腸癌患者の第一または第二選択治療法としてのmFOLFIRI及び連続IRIS+ベバシズマブ治療の安全確認試験
Safety Verification Trials of mFOLFIRI and Sequential IRIS + Bevacizumab as First- or Second-Line Therapies for Metastatic Colorectal Cancer in Japanese Patients
著者 (16件):
KATO Shunsuke
(Tohoku Univ.)
,
ANDOH Hideaki
(Nakadori General Hospital, Akita)
,
GAMOH Makio
(South Miyagi Medical Center, Shibata-gun)
,
YAMAGUCHI Takuhiro
(Tohoku Univ. School of Medicine)
,
MURAKAWA Yasuko
(Miyagi Cancer Center, Medeshima)
,
SHIMODAIRA Hideki
(Tohoku Univ.)
,
TAKAHASHI Shin
(Tohoku Univ.)
,
MORI Takahiro
(Tohoku Univ. Hospital Cancer Center)
,
OHORI Hisatsugu
(Tohoku Univ.)
,
MAEDA Shun-ichi
(Hachinohe City Hospital, Hachinohe)
,
SUZUKI Takao
(Sendai Medical Center, Sendai)
,
KATO Satoshi
(Iwate Prefecture Central Hospital, Morioka)
,
AKIYAMA Shoko
(Tohoku Univ.)
,
SASAKI Yuka
(Tohoku Univ. School of Medicine)
,
YOSHIOKA Takashi
(Yamagata Univ., Yamagaa, JPN)
,
ISHIOKA Chikashi
(Tohoku Univ.)
資料名:
Oncology
(Oncology)
巻:
83
号:
2
ページ:
101-107
発行年:
2012年
JST資料番号:
T0130A
ISSN:
0030-2414
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)